Baseline | Six-months (+/− 4 weeks) | |
---|---|---|
Informed Consent | ✓ | |
Inclusion/Exclusion Criteria | ✓ | |
Demographics | ✓ | |
Medical history (from hospital file) | ✓ | |
Medication adherence (self-reported) | ✓ | ✓ |
Accelerometer provided (n = 32) | ✓ | ✓ |
Primary outcome | ||
Self-efficacy - Self-Efficacy to Manage Chronic Disease Scale (6-items) [35] | ✓ | ✓ |
Secondary outcomes | ||
BMI measured by height in cm by stadiometer and weight in kilograms [36] | ✓ | ✓ |
Total body fat percentage measured with Seca medical Body Composition Analyser (mBCA) 515 with Seca Analytics mBCA 115 software (Seca GmbH & Co. KG, Hamburg, Germany) [37] | ✓ | ✓ |
Waist circumference in cm [36] | ✓ | ✓ |
Physical activity level – GPAQ, a validated measure of mild, moderate and vigorous intense activity, as well as sedentary behaviours [38]. | ✓ | ✓ |
✓ | ✓ | |
Quality of life – measured by a core 30-item quality of life questionnaire, EORTC QLQ-30 AND | ✓ | ✓ |
23-item breast cancer-specific sub-scale EORTC QLQ-BR23, which have been widely used and validated in breast cancer populations [41] | ✓ | ✓ |
Illness perceptions – BIPQ, a validated 9-item measure used to rapidly assess patients’ perceptions of the cognitive and emotional impacts of their illness, including disease severity and causality [42]. | ✓ | ✓ |
Depression and Anxiety - short-form DASS, which has been validated and tested in numerous patient populations [43]. This scale will be collected from participants’ medical file, unless the scale was completed more than one month prior to the study visit, then participants will complete the scale. | ✓ | ✓ |
Randomisation | ✓ | |
Participant feedback survey | ✓ |